Nihon Kohden Corp represents a strong commitment to innovation, quality, and patient-centric care. As a leading manufacturer of medical equipment, the company prioritizes the development and delivery of advanced solutions in the healthcare industry. With a corporate philosophy centered on "Quality First," Nihon Kohden Corp continuously strives to enhance patient outcomes and promote efficiency in medical settings. Through their dedication to technological advancements and customer satisfaction, Nihon Kohden Corp has established itself as a trusted provider of medical devices for hospitals and healthcare professionals worldwide.

Nihon Kohden Corp is primarily present in Japan, with its headquarters located in Tokyo. With a strong presence in the domestic market, the company operates globally and has expanded its business operations to many countries and regions worldwide. Nihon Kohden Corp has a widespread international presence, including subsidiaries and representative offices in various countries such as the United States, Germany, France, China, Brazil, and many more.

Nihon Kohden Corp, a leader in medical equipment manufacturing, has achieved numerous significant milestones throughout its history. The company, founded in 1951, has continuously innovated and provided cutting-edge medical technologies worldwide. Some notable milestones include the development of the first Japanese-made electronic diagnostic electrocardiograph (ECG), the introduction of wireless telemetry monitoring systems, and the launch of advanced patient monitoring devices. Nihon Kohden Corp has also expanded its global presence with subsidiaries and sales offices in various countries. With a strong focus on research and development, this esteemed company continues to revolutionize the healthcare industry with its high-quality products and solutions.

Nihon Kohden Corp is a renowned Japanese company specializing in the manufacturing and distribution of medical electronic equipment. Established in 1951, Nihon Kohden has a rich history of innovation and commitment to advancing healthcare. The company has continuously developed cutting-edge technologies for monitoring, diagnosis, and treatment purposes, ranging from patient monitors to electroencephalographs (EEGs) and other medical devices. Nihon Kohden Corp has built a strong global presence over the years, expanding its operations to numerous countries and collaborating with healthcare professionals worldwide. With a focus on delivering reliable and high-quality medical solutions, Nihon Kohden has earned a prominent reputation in the medical industry.

The main competitors of Nihon Kohden Corp in the market include Philips Healthcare, Medtronic, GE Healthcare, and Siemens Healthineers. These companies are prominent players in the healthcare industry, offering a wide range of medical equipment and solutions. Nihon Kohden Corp competes against these companies primarily in the field of patient monitoring and diagnostics. With its advanced technology and dedicated focus on healthcare, Nihon Kohden Corp strives to maintain its competitive position in the market amid these formidable rivals.

Nihon Kohden Corp is primarily active in the healthcare industry.

Nihon Kohden Corp. operates under the business model of manufacturing and distributing medical equipment and systems for patient monitoring and diagnosis purposes. The company specializes in producing a wide range of medical devices, including electrocardiographs, defibrillators, bedside monitors, EEG and EMG systems, and hematology analyzers. Nihon Kohden Corp. aims to provide innovative and reliable medical solutions to healthcare professionals, contributing to the improvement of patient care and outcomes. With its focus on technological advancements and high-quality products, the company has established a strong presence in the global healthcare market.

Nihon Kohden KGV ir 8,77.

Nihon Kohden KUV ir 0,67.

AlleAktien kvalitātes vērtējums Nihon Kohden ir 4/10.

Nihon Kohden apgrozījums ir 221,99 miljardi JPY.

Nihon Kohden peļņa ir 17,03 miljardi JPY.

Nihon Kohden Corporation is a leading global provider of medical technology and system solutions for the diagnosis and treatment of patients. The company was founded in Japan in 1951 and now has branches and subsidiaries in over 80 countries. The business model of Nihon Kohden is divided into various divisions that together offer a wide range of products and comprehensive services for medical care. The core business areas include clinical diagnostics, electrophysiology, cardiac monitoring, intensive care medicine, and neurology. In clinical diagnostics, Nihon Kohden offers a variety of products and systems for laboratory diagnostics, including automation solutions, infection test kits, hemoglobin analyzers, and urine analysis systems. These products are used to enable rapid and accurate diagnosis and thus optimize patient treatment. In the field of electrophysiology, Nihon Kohden provides products for the precise capture, analysis, and treatment of cardiac arrhythmias. This includes ECG systems, long-term monitoring systems, and devices for electrocardiogram analysis, which significantly contribute to making a correct diagnosis and carrying out targeted therapy. For cardiac monitoring and intensive care medicine, Nihon Kohden offers products such as patient monitors, defibrillators, and ventilation devices that are used for monitoring and emergency treatment of critical patients. These devices are crucial for treating life-threatening situations quickly and effectively. In neurology, the company offers products for monitoring and diagnosing brain diseases, including EEG and EMG systems for measuring electrical currents in the brain or muscle tissue, as well as devices for monitoring brain activity during anesthesia. In addition to these main business areas, Nihon Kohden also offers a wide range of services to support the various products and systems. These include training and support for medical staff in the use of the devices, maintenance and repair, as well as consulting and support for the implementation of information technology solutions. Overall, Nihon Kohden's business model is focused on offering a wide range of products and services tailored to the needs of patients and medical professionals. By focusing on various medical fields, the company ensures that it provides comprehensive medical solutions that contribute to improving the quality of healthcare worldwide.

Nihon Kohden izmaksā dividendes 30,00 JPY, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt Nihon Kohden vai uzņēmums nedod dividendes.

Nihon Kohden ISIN ir JP3706800004.

Nihon Kohden WKN ir 864378.

Nihon Kohden simbols ir 6849.T.

Pēdējo 12 mēnešu laikā Nihon Kohden maksāja dividendes 46,00 JPY apmērā. Tas atbilst aptuveni 2,59 % dividendes ražībai. Nākamajos 12 mēnešos Nihon Kohden plāno maksāt dividendes 51,91 JPY apmērā.

Nihon Kohden pašreizējā dividendu rentabilitāte ir 2,59 %.

Nihon Kohden maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos oktobris, aprīlis, oktobris, aprīlis.

Nihon Kohden pēdējo 23 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 51,91 JPY. Tas atbilst dividendes ražībai 2,92 %.

Nihon Kohden tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu Nihon Kohden apmērā 15 JPY, kas tika izmaksāta 1.12.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 27.09.2024..

Pēdējās dividendes izmaksa notika 1.12.2024..

Gadā 2023, Nihon Kohden izmaksāja 71 JPY dividendes.

Nihon Kohden dividendes tiek izmaksātas JPY.